Impact of fractional exhaled nitric oxide on the outcomes of lung resection surgery: a prospective study
Open Access
- 1 May 2020
- journal article
- research article
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 12 (5) , 2663-2671
Abstract
Background: Fractional exhaled nitric oxide (FeNO), which is representative of airway inflammation, is an indicator of chronic lung disease. However, its effect on the outcome of lung resection is unknown. The aim of this prospective study was to evaluate FeNO in patients who underwent lung resection, to analyze the perioperative dynamics, and clarify the impact on postoperative complications. Methods: We measured FeNO using NIOX VERO® once before and on days 1, 3, 5–7 after surgery in participants who were candidates for lung cancer surgery. The primary endpoint was the relationship between postoperative morbidity and preoperative FeNO. The secondary endpoint was the relationship between postoperative FeNO and additional treatment, including readmission. Results: We enrolled 105 patients between September 2017 and March 2019. Anatomical lung resection was the predominant treatment (87%) for primary lung cancer. Postoperative pulmonary complications developed in 16 patients. Multivariate analysis revealed that preoperative FeNO was a significant predictor of postoperative pulmonary complications (P=0.002, OR: 1.004, 95% CI: 1.016–1.074). FeNO levels increased significantly after surgery (P=0.011). Postoperative FeNO was a significant predictor of the need for additional medical treatment within 30 days of surgery (P=0.001, OR: 1.068, 95% CI: 1.028–1.110). Conclusions: Perioperative FeNO was a significant predictor of surgical outcome among patients who underwent lung resection. The measurement of FeNO is expected to be a simple and useful method for preventing subsequent deterioration in these patients.Keywords
This publication has 16 references indexed in Scilit:
- Postoperative Pulmonary Complications, Early Mortality, and Hospital Stay Following Noncardiothoracic SurgeryJAMA Surgery, 2017
- A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study)Respiratory Research, 2016
- Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPDChest, 2015
- Prevalence and Clinical Relevance of Allergic Rhinitis in Patients with Classic Asthma and Cough Variant AsthmaRespiration, 2013
- An Analysis of Methodologies That Can Be Used to Validate if a Perioperative Surgical Home Improves the Patient-centeredness, Evidence-based Practice, Quality, Safety, and Value of Patient CareAnesthesiology, 2013
- Clinical and economic burden of postoperative pulmonary complications: Patient safety summit on definition, risk-reducing interventions, and preventive strategies*Critical Care Medicine, 2011
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and childrenEuropean Respiratory Journal, 2003
- Nitric Oxide and Protein Nitration are Eosinophil Dependent in Allergen-Challenged MiceAmerican Journal of Respiratory and Critical Care Medicine, 2001
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987